One of the main risks for markets going into Q2 was: how would the European vaccination program evolve. Between the new coronavirus variants and slow vaccination rollout, Europe had to deal with further lockdowns in Q1. The result was a lost first quarter for growth. In terms of fiscal policy, not only has Europe failed to really keep up with the massi…
© 2024 Jonathan Turek
Substack is the home for great culture